Activators of IDI2 function within a complex network of biochemical pathways that are pivotal to the synthesis of isoprenoids. Certain small molecules can enhance IDI2 activity by elevating intracellular levels of precursors and substrates within the mevalonate pathway, where IDI2 plays a critical role. The presence of specific substrates directly fuels the enzymatic function of IDI2, allowing for more frequent catalytic events. This, in turn, results in a higher production rate of the isoprenoid compounds that are vital for various cellular processes. Additionally, the supplementation of cofactors essential for the IDI2 enzymatic action can significantly enhance the catalytic efficiency of the enzyme. When the end products of the mevalonate pathway accumulate, a feedback mechanism may instigate the upregulation of IDI2 activity, ensuring the maintenance of necessary isoprenoid levels.
The activity of IDI2 can also be indirectly influenced by the modulation of upstream enzymes within the same biosynthetic pathway. The use of certain inhibitors that target early-stage enzymes in the pathway can lead to a compensatory upregulation of downstream components, including IDI2. This results in an increased flux through the pathway, thereby elevating the activity of IDI2 to restore balance. Moreover, the utilization of substrates that are part of the isoprenoid biosynthesis pathway not only provides the necessary components for IDI2-mediated reactions but also potentially signals through feedback loops to maintain enzymatic activities at optimal levels.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Elevates intracellular cAMP levels, which can enhance the activity of IDI2 by increasing the synthesis of isoprenoids. | ||||||
Geranylgeranylpyrophosphate triammonium salt | 6699-20-3 | sc-200849 | 200 µg | $120.00 | ||
Serves as a substrate for IDI2, providing it with more opportunity to exert its isomerase activity. | ||||||
Squalene | 111-02-4 | sc-281155 sc-281155A sc-281155B | 10 ml 100 ml 500 ml | $48.00 $90.00 $211.00 | 1 | |
End product of the pathway IDI2 is involved in; its feedback could upregulate IDI2's activity by substrate availability. | ||||||
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $28.00 $88.00 $332.00 | 12 | |
Inhibitor of HMG-CoA reductase, leading to compensatory upregulation of the mevalonate pathway and IDI2 activity. | ||||||
Farnesyl pyrophosphate ammonium salt | 13058-04-3 | sc-200847 sc-200847A | 1 mg 5 mg | $469.00 $1938.00 | ||
As a substrate in the mevalonate pathway, it can increase IDI2 activity to produce its isomers. | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $30.00 $87.00 $132.00 $434.00 | 13 | |
Inhibits HMG-CoA reductase, which can lead to increased IDI2 activity. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $47.00 | ||
As a cofactor, zinc can enhance the catalytic efficiency of IDI2 in the isoprenoid biosynthesis pathway. | ||||||